维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Wheler"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	α2-adrenoreceptor agonists are neuroprotective in rat model of optic nerve degeneration显示文摘	Wheler LA Schwartz M	1999	Invest Ophthalmol Vis Sci1999，40，：	1
2	PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations显示文摘	Janku F Wheler J J Westin S N		0，，08：	1
3	PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations显示文摘	Janku F Wheler JJ Westin SN	2012	J Clin Oncol2012，30，8：	1
4	Temporal and spatial variation in stocks of autotrophic and heterotrophic microbes in the upper water column of the central Arctic Ocean显示文摘	SHERR E B SHERR B F WHELER P A	2003	Deep-Sea Res2003，50，：	1
5	Inhibi- tion of the Ras/Ra{/MEK/ERK and RET kinase pathways with the combination of the multikinase in- hibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid ma- lignancies显示文摘	Hong DS Cabanillas ME Wheler J	2011	J Clin Endocrinol Metab2011，96，4：	1
6	Androgen receptors beyondprostate cancer : an old marker as a new target显示文摘	Munoz J Wheler J J Kurzrock R	2015	Oncotargel2015，6，2：	1
7	Detemine of tabeue acidic aminoethylsulfonic显示文摘	Wheler GHT	1981	J Liq Chromatogr1981，4，7：	1
8	Safety, pharmacoki- netics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies显示文摘	Kurzrock R Goel S Wheler J	2012	Cancer2012，118，24：	1
9	PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations显示文摘	Janku F Wheler JJ Westin SN	2012	J Clin Oncol2012，30，：	1
10	Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma,neural tumors and nevi显示文摘	Shah I A Gani O S Wheler L		0，，07：	1
11	Phase I Clinical Trials in 93 Patients with Brain Metastases: The M. D. Anderson Cancer Center Experience显示文摘	Tsimberidou AM Letourneau K Wen S Wheler JJ Hong DS Naing A Iskander NG Uehara C Kurzrock R	2011	中国神经肿瘤杂志2011，9，1：	1
12	Anastrozole and everolimus in advanced gynecologic and breast malignancies:activity and molecular alterations in the PI3K/AKT/mTOR pathway显示文摘	Wheler JJ Moulder SL Naing A		Oncotarget0，5，10：	1
13	High expression of the chemokine receptor CCR7 is associated with worse outcome in breast cancer显示文摘	Abu-Khalaf MM Wheler J Zerkowski M	2005	ASCO Meeting Abstracts2005，23，16：	1
14	Dual HER2inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer显示文摘	Falchook GS Moulder SL Wheler JJ	2013	Ann Oncol2013，24，12：	1
15	A phase 1 safety and pharmacokinetic (PK) study of the PI3K inhibitor XL147 (SAR245408) in combination with paclitaxel (P) and carboplatin (C) in patients with advanced solid tmors显示文摘	Wheler JJ Bailey HH	2009	Mol Cancer Ther2009，8，1：	1
16	PI3K/AKT /roTOR inhibitors in patients with breast and gynecologic malignancies bartering PIK3CA mutations 显示文摘	Janku F Wheler JJ Westin SN	2012	J Clin Oncol2012，30，8：	1
17	Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer 显示文摘	Falchook GS Moulder SL Wheler JJ	2013	Ann Oncol2013，24，12：	1
18	Inhibition of the Ras/ Raf/MEK/ERK and RET kinase pathways with the combination of the muhikinase inhibitor sorafenib and the farnesyhransfer- ase inhibitor tipifamib in medullary and differentiated thyroid malignancies 显示文摘	Hang DS Cabanillas ME Wheler J	2011	J Chn Endocrinol Metabol2011，96，4：	1
19	Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-in-induced liver injury in rats显示文摘	Wheler MD Kono H Yin M	2001	Gastroenterology2001，120，：	1
20	Determine of tabeue acidic aminoethylesulfonic显示文摘		1981	J Liq Chromatogr1981，4，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示